Invest in the future of medicine

Continuity, transparency and trust — that is what Investor Relations stands for at MediCrops Holding AG. MediCrops® is an internationally operating pharmaceutical company headquartered in Switzerland specializing in prescription-only cannabis preparations containing THC. Our subsidiary MediCrops® North Macedonia possesses an official licence issued by the Ministry of Health. In conformity with the highest GMP (good manufacturing practice) standards, it will operate a high-tech indoor cultivation for the production and development of pharmaceuticals in their in-house laboratory. Thanks to our excellent market position, our long-standing experience and our international network composed of internal and external highly qualified specialists, there are outstanding growth opportunities on the international markets. We would be delighted if we succeeded in arousing your interest in our company. Trust our expertise and rely on our future-proof business model.